Gestational Hypertension

NICaS is designed to assist physicians to determine the exact cause of hypertension for preeclampsia management. NICaS is based on patients’ objective hemodynamic parameters, allowing physicians to reach a deeper understanding of the dynamics concerning each patient’s hypertension and to improve preeclampsia management.

Challenges

  • Preeclampsia and eclampsia significantly increase the risks of maternal and perinatal adverse outcomes. These may include placental abruption, preterm birth, and low birthweight.
  • Preeclampsia management focuses primarily on maternal hypertension therapy. This can reduce the risk of severe hypertensive episodes and safely prolong gestation.
  • There is no accepted standard for the management of preeclampsia.

Solutions

  • With NICaS, physicians can more effectively prescribe the proper medication for the right cause of hypertension.
  • Enabling personalized treatment suited to the individual hemodynamic profile.
  • NICaS data can assist in eliminating hypertension as a risk factor that can cause complications during pregnancy: preeclampsia, etc.

Preeclampsia In Numbers:

10%

of all pregnancies are impacted by hypertension

14%

of all maternal deaths worldwide are due to hypertensive disorders

46%

of women with gestational hypertension will progress to preeclampsia

Contact Us

Related Clinical Studies

Contact Us

Topic

Locate a Distributor
Find the NICaS partner in your region